Overview

• Two doctors have filed a formal complaint alleging unauthorized clinical trials in the nephrology department of Hôpital Édouard-Herriot in 2023.
• The trials reportedly involved an unapproved combination of Basiliximab and Rituximab, with the latter lacking authorization for transplant patients.
• Whistleblowers claim the treatments were administered without proper informed consent or adherence to regulatory protocols.
• The alleged practices are said to have caused the death of a 67-year-old patient and worsened the health of four others.
• Hospital officials deny the allegations, asserting that treatment decisions were made collectively and unrelated to the patient’s death, while investigations are ongoing.